💚 Health & Wellness
Today's top 5 stories, curated by Daily Direct.
Health insurance premiums are set to climb again, continuing a trend that has strained household budgets and employer benefit plans alike. The increases come alongside broader turbulence in the health sector, including the FDA tightening its grip on online ketamine providers. For consumers and businesses already navigating a volatile benefits landscape, the timing could not be worse.
Read article →Researchers at Umeå University have developed a cancer drug composed entirely of human proteins that shows promise in inhibiting both tumor growth and metastasis in aggressive prostate cancer. The findings, published in *Signal Transduction and Targeted Therapy*, mark a potentially significant advance in treating one of the deadliest forms of the disease. Because the drug is built from human proteins, it may face fewer compatibility and immune-response hurdles than conventional synthetic compounds.
Read article →Early-stage lung cancer has long eluded reliable non-invasive detection, but a newly identified blood-based biomarker may change that. Researchers have found the marker can both flag the disease in its earliest phases and forecast patient outcomes — two capabilities rarely combined in a single diagnostic tool. Published in the Journal of Extracellular Vesicles, the findings could meaningfully shift how clinicians screen and stratify lung cancer patients.
Read article →A new AI-powered blood test being trialled across two NHS trusts could eliminate the need for transvaginal ultrasound scans in some womb cancer investigations. Around 90,000 postmenopausal women in England are referred annually for womb cancer checks due to abnormal bleeding, many of whom currently undergo the invasive procedure. If proven effective, the test could significantly reduce patient discomfort while maintaining diagnostic accuracy.
Read article →Researchers at Cambridge University have found compelling evidence linking long-term air pollution exposure to a heightened risk of developing Parkinson's disease. The findings, drawn from a critical review of existing studies, suggest environmental factors play a more significant role in the neurodegenerative condition than previously understood. The research adds urgency to public health arguments for stricter air quality standards.
Read article →Join thousands of readers who get the world's most important stories, curated daily.
Start reading free →